Scientists Visualize How Therapeutic Antibody Binds to SARS-CoV-2 Variants - Technology Networks

Last year, scientists studied the blood of 14 COVID-19 survivors to find the most potent antibodies against the SARS-CoV-2 virus. One of the leading molecules, an antibody dubbed J08, is now in clinical trials in Italy. Now, the same group has visualized exac…

Last year, scientists at Scripps Research and Toscana Life Sciences studied the blood of 14 COVID-19 survivors to find the most potent antibodies against the SARS-CoV-2 virus. One of the leading mole… [+4116 chars]

full article...